Interview by Kev Kharas Photography byDamien Maloney Courtesy: Unlimited.World
(March 22, 2017, Boston, Sri Lanka Guardian) Russian-born Maria Konovalenko is one of the most visible faces at work in the pro-longevity community today. A zealous advocate for the fight against human ageing and a PhD scientist and researcher at the trailblazing Buck Institute in California, her ultimate goal is to use advances in science and technology to help people live the longest, healthiest lives they possibly can.
Her ethos that ageing and dying should be seen as diseases that humanity can work together to cure challenges everything we understand about natural life cycles. It also hints at the possibilities that lie ahead for radical human lifespan extension an extra 30 years in her lifetime, she conservatively estimates, then rapidly up to 200, 300. Beyond that, lies the rather more distant goal of human immortality.
VICE: Can you give me a broad overview what youre up to currently?
Maria K:Im in the third year of my PhD inBiology of Aging, set up by USC and the Buck Institute, the leading organisations in the field. I became a student here in the programmes first year so basically it started with us, were the guinea pigs. I feel incredibly privileged. Im focusing on ageing and stem cells in mouse tracheas were trying to figure out which genes are responsible for the failure of tissue to replenish itself.
With the emergence of things like the Google-fundedCalico Labs, would you say theres been a more concerted push to understand the secrets of immortality in recent years?
Not immortality. Were way off that. What were looking at now are the basic mechanisms that drive ageing, figuring out why our bodies lose their regenerative potential over time. Some people are answering different questions for example, why do we develop neurodegenerative pathologies, like Alzheimers? Were all looking at different mechanisms and then trying to interfere with them to slow down ageing. You can extend the lifespan of a worm ten times thats unbelievable! but when you look at more complex animals, like mammals, its not as effective.
What do you think we can expect within the limits of our lifetime?
If youre in your sixties or seventies, hopefully, within the next decade or so, well have a therapy that will extend your health span the years in which youre generally healthy and free from disease. Thats based on recent discussions at one of the big ageing conferences, and what some of the key biologists believe. If youre in your thirties, your life expectancy and the probability of more breakthrough techs being developed is way higher.
We could develop a combination of things that have a synergistic effect. For example: the Buck Institutes Dr Pankaj Kapahi created a worm that had two tailored genetic mutations if administered separately, these mutations had been shown to give about 100 and 60 percent extra lifespan, respectively. But, administered together, they didnt yield to a 160 percent increase in lifespan it was actually an increase of almost 500 percent!
How could AI help expand human lifespan?
AI could change the fate of humanity. People in biology are already dealing with tons of data, but AI would be able to come up with models and predictions based on the entire breadth of existing human knowledge in biology, very quickly. Heres an example: the IBM AI-supercomputer Watson was able to digest all our collective cancer knowledge and diagnose cancer patients more accurately than human physicians. AI wouldnt just be the tool that scientists use it would be the scientist.
What kind of opportunities could radically extended lifespans give us as a species?
I think that liberation from biological ageing is one of the most wonderful things that could happen to humans. We could end pain, disease, suffering; we could go to different planets, deal with the technological problems that space travel poses, create new worlds.
What do you think the global economy might look like in such a world?
Everything would immediately be different in a world with AI. Its very hard to make any meaningful predictions beyond its arrival. But I believe that when it does, technological progress will be the main driver of the economy. The economy of the previous two centuries was driven by what was inside the Earth oil, gas, things like that. Right now, the most expensive companies are tech companies.
If people were born into a world with the expectation of significantly longer life 200, 300 years what do you think would happen to punishments for crimes likemurder?
It would be costly for the government to keep criminals alive in prison for 200, 300 years. Wed have to rethink our old penitentiary system. If a person has done something wrong, maybe we could use tech to change underlying psychological factors that caused the person to commit the crime in the first place. Maybe well come up with a neurotransmitter cocktail, for example, that lets us treat criminals as if violence is a curable disease?
How about the ideal of romantic monogamy if people are living much longer, will they still want to spend their entire lives with one person?
People are very interesting creatures because our relationships adapt and change along with us. I know I might sound extremely optimistic, but there are way too many dystopias in the movies; how might the world look if everything goes right? If the future-society changes so much that monogamys no longer beneficial for an individual, then people will adapt. Chances are the number of pairs staying together for life will decrease. But I dont think it will hit zero.
As a generation, what kind of legacy do you think we should be looking to leave behind?
Definitely extending lifespan and health-span by somewhere in the region of 30 percent. This will happen within the coming few decades. As for the bigger legacy, people are building the base of the algorithms that will hopefully create AI in the more distant future. So that will probably be part of our legacy, too.
Do you believe in life after death?
I dont. However, have you seenBlack Mirror? The San Junipero episode I believe thats a very basic, optimistic representation of what mind uploading might look like in the future. If you could somehow transfer consciousness from a biological subject into some kind of storage device that could be life after death.
Is that something youd enjoy?
Absolutely. I dont want to die. You would be forever young.
Why would you like to live forever?
I would like to implement my dreams. And they range from having a pair of wings, to being able to drink a cocktail in a bar on Mars, to solving the existing problems of the world economic inequality, diseases that make our lives miserable, things like that. I have an endless list of dreams. And thats why I need an endless amount of hours.
Featured image: Maria at the Buck Institute for Research on Aging in Novato, California, credit Damien Maloney
Link:
Science to Beat the Death: 200 300 years old human in the Future! - Sri Lanka Guardian
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021